JoVE Logo

Zaloguj się

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

9.1K Views

09:43 min

March 30th, 2018

DOI :

10.3791/56515-v

March 30th, 2018


Przeglądaj więcej filmów

NK Cells

Rozdziały w tym wideo

0:04

Title

1:35

Isolation of PBMC from CAEBV Patients

2:59

Expansion of Cells and Numbering the Viable Cells

4:08

Preparation for Cell Phenotyping by Flow Cytometry

5:52

Expansion and Cryopreservation of NK/T Cells

7:23

Results: Representative Gating Strategy for Flow Cytometry Analysis of Cell Lines L196 and M296

8:25

Conclusion

Powiązane Filmy

article

12:07

Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays

25.9K Views

article

08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

17.1K Views

article

06:38

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

40.0K Views

article

11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

12.7K Views

article

13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

12.3K Views

article

11:02

Natural Killer (NK) and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

5.4K Views

article

09:49

A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines

14.8K Views

article

08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

2.3K Views

article

09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

3.6K Views

article

07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

2.4K Views

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone